Melanoma - /contrib/melanoma

Sorted by: Last Commented | Last Added Time
Personalised melanoma vaccines prolong survival in largest trial yet...
Submitted to Category: /contrib/melanoma, /contrib/health/
People who received a personalised melanoma skin cancer vaccine on top of a standard treatment were 44 per cent less likely to die over the study period than those who had the standard treatment alone
By Anonymous Submission on 2022-12-30 03:45 UTC
Artificial DNA kills cancer...
Researchers have used artificial DNA to target and kill cancer cells in a completely new way. The method was effective in lab tests against human cervical cancer- and breast cancer-derived cells, and against malignant melanoma cells from mice. The team cr
By Anonymous Submission on 2022-12-23 03:27 UTC
How cancer cells can become immortal new research finds a mutated gene that helps melanoma defeat the normal limits on repeated replication...
Submitted to Category: /contrib/health/, /contrib/melanoma
(THE CONVERSATION) A defining characteristic of cancer cells is their immortality. Usually, normal cells are limited in the number of times they can divide before they stop growing. Cancer cells, however, can overcome this limitation to form tumors and by
By Anonymous Submission on 2022-11-13 21:51 UTC
Merck pays $250M to license Moderna cancer vaccine...
Submitted to Category: /contrib/health/, /contrib/melanoma
The drugmakers decision to grab rights to the shot deepens its ties with the COVID-19 vaccine developer and comes weeks before a key data release.
By kynast on 2022-10-25 16:38 UTC
A cancer vaccine could be ready in MONTHS: Drug giant Merck teams with Moderna to develop cancer jab...
The new shot - designed by Boston biotech Moderna for people with high-risk melanoma - is in the second of three trials and a verdict on whether it works or not is expected within months.
By Anonymous Submission on 2022-10-14 16:34 UTC
Fianlimab (LAG-3 Inhibitor) Combined with Libtayo® (cemiplimab) Demonstrates Greater than 60% Response Rates in Two Independent Cohorts of Patients with Advanced Melanoma Naïve to PD-1 or PD-L1 Inhi...
Submitted to Category: /contrib/health/, /contrib/melanoma
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the presentation of positive data from multiple expansion cohorts of an initial Phase 1 trial for an investigational combination of LAG-3 inhibitor fianlimab and PD-1 inhibitor Libtayo® (cemiplimab) in advanced melanoma. The results
By Anonymous Submission on 2022-09-12 13:39 UTC
Antibiotics might worsen melanoma cancer by depleting gut microbiome: Study...
Submitted to Category: /contrib/health/, /contrib/melanoma
According to a new study by researchers at Emory University in Atlanta, the use of broad-spectrum antibiotics in mice with malignant melanoma, an aggressive form of skin cancer
By Anonymous Submission on 2022-09-12 13:34 UTC
Blood test may accurately diagnose melanoma, study finds...
Testing a person's blood for the presence of circulating melanoma cells may help identify skin cancer, while allowing them to skip invasive biopsies, a study published Wednesday found.
By kynast on 2022-04-26 22:48 UTC
How to Tell Whether a Cancer Is Caused by Plain Bad Luck...
A new study offers a possible answer to the question "Why me?" Confirming epidemiological studies, they found that melanomas and lung, bladder and cervical cancers are largely attributable to exposure to carcinogens such as UV light and tobacco, whereas brain and spinal cord tumors called gliomas
By kynast on 2022-04-26 22:45 UTC

Page 1 of 1

  • Need an account?